Impact of the SCS With Different Waveforms Over the Quality of Life (SCS-Quality)
Unknown statusNot applicableNCT04244669
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Prospective, randomized, multicentre, parallel, controlled, and double-blind trial. It is a study with 2 groups with evaluation pre and post treatment with Spinal Cord Stimulation (SCS) implantation of patients with Failed Back Surgery Syndrome (FBSS). The study has been designed to assess primarily non-inferiority and secondarily superiority of SCS DTM therapy
Study details
- Official title
- The Impact of Different Spinal Cord Stimulation Waveforms on Quality of Life in Patients With Chronic Pain (SCS-Quality)
- Conditions
- Failed Back Surgery Syndrome
- Spinal Cord Stimulation
- Interventions
- Device: IPG with Conventional Stimulation
- Device: IPG with SCS DTM
- Sponsor
- Pablo López Pais
- Organization
- Hospital Clinico Universitario de Santiago
- Start date
- 2020-11-26
- Primary completion
- 2023-06
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Leg with/without Low back pain with neuropathic characteristics (VAS ≥ 5 and DN4≥4) during at least 6 months before the screening consultation. * Stable medical therapy with Evidence Based Medicine (EBM) during at least one month before the screening * Ready and able to accomplish the procedures of the study and use the activity monitor and the medication diary. * Have 18 years old or older when the patient signs the informed consent * Pain kept during at least the last 6 months with VAS ≥ 6 and functional limitation due to the pain * Refractory to treatment (during at least 3 months), and/or * Intolerable adverse effects that avoid an optimum medical treatment * Previous lumbosacral surgery for treatment of the cause of his pain * Pain attributable to a low back pathology Exclusion Criteria: * Pregnant or with planned pregnancy * Life expectancy \<1 year. * Polyneuropathy. * Important Heart disease or peripheral vascular disease * Degenerative disease that can decrease the functional capacity * Alcoholism - Drug abuse * Active infection * Oncological active disease * Haematological disorder with increased bleeding risk * Patient unable to understand / follow the target of the study and the work flow * When trial period has finished, the negative clinical response will be considered an exclusion criterion. The treatment could be completed, and the data collected but the patient will be excluded of the Randomized Clinical Trial (RCT) and the data analysed separately.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04244669